Home › Large 'pay for delay' fine imposed by CMA
 

Keywords :   


Large 'pay for delay' fine imposed by CMA

2016-02-16 20:09:31| Biotech - Topix.net

On the 12th of February 2016, the UK Competition and Markets Authority fined GlaxoSmithKline and the successor companies to Alpharma Limited around 45m in total for breaches of Chapter I of the Competition Act 1998, the prohibition against anti-competitive agreements. The case shows the continued danger in pharmaceuticals reaching settlement agreements in IP disputes with generic drug providers.

Tags: large pay fine delay

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Acreage and stocks estimates push corn prices lower
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
More »